Full Press Release Details
Solid Biosciences Provides Interim Positive Clinical Update.
SLDB
Solid Biosciences Provides Interim Positive Clinical Update
Key Takeaway: Solid Biosciences Provides Interim Positive Clinical Update
Price reaction · baseline $8.18 (2026-03-10 close) · hit after-hours · clean, no other SLDB news in the window
day 0 close
-5.7%
day 1
-5.7%
day 3 · peak
-8.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma